12e8:H (VAL2) to (SER112) 2E8 FAB FRAGMENT | IMMUNOGLOBULIN
12e8:P (VAL2) to (SER112) 2E8 FAB FRAGMENT | IMMUNOGLOBULIN
4grw:G (GLN3) to (VAL119) STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS) | CYTOKINE, IMMUNOGLOBULIN FOLD, VHH DOMAIN, IMMUNE SYSTEM
4gsd:H (VAL2) to (THR120) H5.3 FAB STRUCTURE | ANTIBODY, IMMUNE RESPONSE, INFLUENZA H5 HEMAGGLUTANIN, IMMUNE SYSTEM
1a14:H (VAL2) to (VAL111) COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE | COMPLEX (ANTIBODY-ANTIGEN), SINGLE-CHAIN ANTIBODY, GLYCOSYLATED PROTEIN, COMPLEX (ANTIBODY-ANTIGEN) COMPLEX
1n8z:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB | TYROSIN KINASE RECEPTOR, CELL SURFACE RECEPTOR, TRANSFERASE
1nam:B (LEU3) to (VAL116) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM
2ajz:H (GLU1) to (VAL111) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER | CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, HYDROLYTIC, IMMUNE SYSTEM
4wfe:E (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wfe:G (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wff:E (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wff:G (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wfg:E (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wfg:G (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wfh:E (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
4wfh:G (VAL2) to (SER115) HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION | MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN
1a6t:B (VAL2) to (SER112) FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE | IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1
1a6u:H (VAL302) to (VAL418) B1-8 FV FRAGMENT | IMMUNOGLOBULIN
1a6v:J (VAL302) to (VAL418) B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND | IMMUNOGLOBULIN, HAPTEN, IMMUNE SYSTEM
1a6w:H (VAL302) to (SER419) B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND | IMMUNOGLOBULIN, HAPTEN
4gw4:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION | FWR, IGG, ANTI HIV, GP120, HIV, IMMUNE SYSTEM
4gw4:A (VAL2) to (SER118) CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION | FWR, IGG, ANTI HIV, GP120, HIV, IMMUNE SYSTEM
4gw5:B (VAL2) to (SER118) CQYN MEDITOPE - CETUXIMAB FAB | IGG, IMMUNE SYSTEM, EGFR
4gw5:D (VAL2) to (SER118) CQYN MEDITOPE - CETUXIMAB FAB | IGG, IMMUNE SYSTEM, EGFR
1ngp:H (VAL2) to (SER119) N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE | IMMUNOGLOBULIN,
2arj:H (VAL2) to (SER112) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
2arj:B (VAL2) to (ALA111) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
3eff:B (GLN3) to (SER123) THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION | FULL LENGTH KCSA, BULGE HELIX, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE- GATED CHANNEL, MEMBRANE PROTEIN
1nmb:H (VAL2) to (VAL111) THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY | COMPLEX (HYDROLASE-IMMUNOGLOBULIN), COMPLEX (HYDROLASE- IMMUNOGLOBULIN) COMPLEX
1nmc:H (VAL2) to (SER112) COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE | COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX (SINGLE- CHAIN ANTIBODY-ANTIGEN) COMPLEX
1nmc:B (VAL2) to (SER112) COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE | COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX (SINGLE- CHAIN ANTIBODY-ANTIGEN) COMPLEX
4h0g:A (ILE3) to (SER119) CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV | MOLECULAR MIMICRY, ANTIGEN BINDING, SUGAR, IMMUNE SYSTEM
2op4:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9 | IMMUNOGLOBULIN, ANTIBODY, FAB, INDUCED FIT, QUORUM SENSING, HOMOSERINE LACTONE, IMMUNE SYSTEM
4h20:H (VAL2) to (SER118) CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18 | IG, ANTI RICIN ANTIBODY FAB FRAGMENT, RICIN A CHAIN, EXTRACELLULAR, BLOODSTREAM, IMMUNE SYSTEM
1nqb:C (VAL2) to (SER119) TRIVALENT ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, MULTIVALENT ANTIBODY, DIABODY, DOMAIN SWAPPING, IMMUNOGLOBULIN
2osl:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE | FAB-PEPTIDE COMPLEX, RITUXIMAB, CHIMERIC ANTIBODY, IMMUNE SYSTEM
2osl:A (VAL2) to (VAL119) CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE | FAB-PEPTIDE COMPLEX, RITUXIMAB, CHIMERIC ANTIBODY, IMMUNE SYSTEM
1ap2:D (GLN3) to (PRO120) SINGLE CHAIN FV OF C219 | SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, IMMUNOGLOBULIN
4h88:H (VAL2) to (SER118) STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230 | C-TERM MOUSE PRION PROTEIN, POM1 FAB, IMMUNE SYSTEM
4h8w:H (GLU1) to (VAL111) CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4. | HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2oz4:H (VAL2) to (SER113) STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION | IGSF DOMAIN, STRUCTURAL PLASTICITY, CELL-SURFACE DIMERIZATION, CELL ADHESION
3esv:G (GLN1003) to (SER1112) CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 | SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
2p7t:A (GLN3) to (SER117) CRYSTAL STRUCTURE OF KCSA MUTANT | KCSA, MEMBRANE PROTEIN
3s35:H (VAL2) to (SER116) STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES | ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4hjj:H (THR3) to (SER118) STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE | DFAB COMPLEX, IL-18, DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, IMMUNE SYSTEM
3eyu:H (THR3) to (SER122) PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525) | FAB, AMYLOID, ALZHEIMER'S, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM
3ezj:F (GLN1) to (SER120) CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY | GENERAL SECRETORY PATHWAY, SECRETIN, SINGLE CHAIN ANTIBODY, PROTEIN TRANSPORT, IMMUNE SYSTEM, COMPLEX
3f12:B (VAL2) to (SER124) GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS | HUMAN CYTOMEGALOVIRUS, ANTIBODY, GERMLINE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
2bob:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA) | IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX
1bql:H (LEU4) to (SER115) STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME | ANTIBODY/ANTIGEN COMPLEX, HYHEL-5, ANTI-LYSOZYME, BOBWHITE QUAIL
2brr:Y (VAL2) to (SER112) COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34) | IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX
4x80:H (LYS3) to (VAL122) CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5 | MONOCLONAL, IMMUNE SYSTEM
1oay:J (VAL2) to (SER119) ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY | IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY
4hs6:B (GLU1) to (VAL111) HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362 | IMMUNE SYSTEM
4hs6:H (GLU1) to (VAL111) HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362 | IMMUNE SYSTEM
4xaw:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA) | HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM
4xbp:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
4xbp:E (GLN1) to (GLN105) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
3fct:B (VAL2) to (SER113) MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN | METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
4xce:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xcf:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC) | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
3se8:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC03, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4i0c:C (GLN3) to (SER125) THE STRUCTURE OF THE CAMELID ANTIBODY CABHUL5 IN COMPLEX WITH HUMAN LYSOZYME | BETA-BARREL, ALPHA-BETA PROTEIN, IMMUNE RECOGNITION, GLYCOSIDASE, IMMUNE SYSTEM-HYDROLASE COMPLEX
1c5c:H (VAL2) to (SER112) DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, HAPTEN COMPLEX, IMMUNE SYSTEM
3fo1:B (VAL2) to (VAL119) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1op9:A (GLN1) to (SER120) COMPLEX OF HUMAN LYSOZYME WITH CAMELID VHH HL6 ANTIBODY FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, IMMUNOGLOBULIN, AMYLOID FIBRIL FORMATION INHIBITION, HYDROLASE
1ck0:H (VAL2) to (SER116) ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM | IMMUNOGLOBULIN
1orq:B (ASP1) to (SER117) X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB | POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, KVAP, FAB COMPLEX, MEMBRANE PROTEIN
4i9w:E (VAL2) to (SER115) HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE | POTASSIUM ION CHANNEL, METAL TRANSPORT
4i9w:G (VAL2) to (SER115) HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE | POTASSIUM ION CHANNEL, METAL TRANSPORT
3stl:A (GLN3) to (SER117) KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND | CADMIUM, TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, MEMBRANE PROTEIN
3stz:A (GLN3) to (SER117) KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL | TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, SPIN-LABEL, MEMBRANE PROTEIN
2q76:B (VAL2) to (SER115) MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT | ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM
2q76:D (VAL2) to (SER115) MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT | ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM
4xnm:H (GLN1) to (SER122) ANTIBODY INFLUENZA H5 COMPLEX | ANTIBODY, INFLUENZA, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xnm:B (GLN1) to (SER122) ANTIBODY INFLUENZA H5 COMPLEX | ANTIBODY, INFLUENZA, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xnq:B (GLN1) to (THR120) ANTIBODY HEMAGGLUTININ COMPLEXES | ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xnq:H (GLN1) to (SER122) ANTIBODY HEMAGGLUTININ COMPLEXES | ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xnx:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH REBOXETINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX
4xny:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4xnz:B (LEU4) to (SER119) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4xnz:E (LEU4) to (SER119) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
2qad:D (GLN3) to (VAL111) STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4 | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2qad:H (GLN3) to (VAL111) STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4 | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3sy0:B (VAL2) to (VAL109) S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM
4xp5:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO COCAINE ANALOGUE-RTI55 | INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX
4xp9:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT D-AMPHETAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, MEMBRANE PROTEIN, PROTEIN TRANSPORT, TRANSPORT PROTEIN-INHIBITOR COMPLEX
4xpg:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428 | ALL ALPHA-HELICAL INTEGRAL MEMBRANE PROTEIN, TRANSPORT PROTEIN- INHIBITOR COMPLEX
4xph:H (VAL2) to (VAL117) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 3,4DICHLOROPHENETHYLAMINE | INTEGRAL MEMBRANE PROTEIN, NEUROTRANSMITTER TRANSPORTER, PROTEIN TRANSPORT-INHIBITOR COMPLEX
2ck0:H (VAL2) to (VAL115) ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE | IMMUNOGLOBULIN
4xrc:B (GLN1) to (VAL121) ANTIBODY HEMAGGLUTININ COMPLEXES | ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xrc:H (GLN1) to (SER122) ANTIBODY HEMAGGLUTININ COMPLEXES | ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3g6j:F (GLN3) to (VAL111) C3B IN COMPLEX WITH A C3B SPECIFIC FAB | COMPLEMENT, C3B, FAB, ANTIBODY:ANTIGEN, AGE-RELATED MACULAR DEGENERATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, COMPLEMENT ALTERNATE PATHWAY, COMPLEMENT PATHWAY, DISEASE MUTATION, GLYCOPROTEIN, IMMUNE RESPONSE, INFLAMMATORY RESPONSE, INNATE IMMUNITY, PHOSPHOPROTEIN, SECRETED, THIOESTER BOND, IMMUNE SYSTEM
2cmr:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX | IMMUNE SYSTEM, IMMUNOGLOBULIN COMPLEX, NEUTRALIZATION, IMMUNOGLOBULIN, ENVELOPE PROTEIN, HIV, GP41, AIDS, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN
3gb7:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ | ION-CHANNEL, ION SELECTIVITY, POTASSIUM TRANSPORT, LITHIUM BLOCK, MEMBRANE PROTEIN, INTEGRAL MEMBRANE PROTEIN, VOLTAGE-GATED POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL
3gbm:H (GLU1) to (SER112) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
3gbm:I (GLU1) to (SER112) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
1dn0:B (GLU1) to (SER119) STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ | FAB, IGM, ANTIBODY, COLD AGGLUTININ, HUMAN, IMMUNE SYSTEM
3t3m:E (VAL2) to (SER118) A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS | INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET
3t3p:E (VAL2) to (SER118) A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS | INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET
4xwo:U (GLN6) to (SER121) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
3t77:B (VAL2) to (VAL109) S25-2- A(2-4)KDO DISACCHARIDE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM
3gk8:H (VAL2) to (SER118) X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14, MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS | ANTIBODY FRAGMENT FROM NEUTRALIZING MONOCLONAL ANTIBODY AGAINST CANINE PARVOVIRUS, IMMUNE SYSTEM
3gkz:A (GLU9) to (VAL124) CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE | THERAPEUTIC ANTIBODY, METHAMPHETAMINE, AMPHETAMINE, MDMA, IGG, IMMUNE SYSTEM
3gnm:H (VAL2) to (SER117) THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT | ANTIBODY, IMMUNOGLOBULIN, JAA-F11, THOMPSON-FRIEDENREICH ANTIGEN, IMMUNE SYSTEM
3go1:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
2r0w:H (THR3) to (VAL111) PFA2 FAB COMPLEXED WITH ABETA1-8 | IMMUNOGLOBULIN; ALZHEIMER DISEASE; AMYLOID, IMMUNE SYSTEM
2r1w:B (VAL2) to (VAL109) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION, SECRETED, IMMUNE SYSTEM
2r1y:B (VAL2) to (VAL109) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1e6j:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5 | HIV CAPSID PROTEIN (P24), P24, FAB, HIV-1, VIRUS ASSEMBLY, CAPSID, CA, ANTIGEN, ANTIBODY, PROTEIN-PROTEIN INTERACTIONS, VIRAL PROTEIN
4j8r:B (LYS3) to (SER112) STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT | IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM
4jb9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE | HIV-1, GP120, ANTIBODY, VRC06, GLYCOPROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1q72:H (VAL2) to (VAL111) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
2dqf:B (GLN3) to (THR110) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (Y33AY53A) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
1q9o:B (VAL2) to (VAL109) S45-18 FAB UNLIGANDED | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3tnn:A (VAL2) to (VAL111) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
4jfx:B (VAL2) to (SER112) STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4jfx:H (VAL2) to (SER112) STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
2rcs:H (GLN3) to (SER112) IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY | GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY MATURATION
4yc2:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32. | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2dwd:A (GLN3) to (SER117) CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
2dwe:A (GLN3) to (SER117) CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
1qfu:H (VAL2) to (SER112) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMMUNOGLOBULIN), HEMAGGLUTININ, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ydl:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4jkp:H (VAL2) to (SER116) RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES | IGG, ANTIBODY, GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2e27:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3tv3:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9 | FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM
1qlr:D (GLU1) to (SER119) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ | IMMUNOGLOBULIN, AUTOANTIBODY, COLD AGGLUTININ, HUMAN IGM FAB FRAGMENT
3h3p:H (GLN1) to (SER126) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX | EPITOPE-SCAFFOLD FV COMPLEX, IMMUNE SYSTEM
3h3p:I (GLN1) to (GLN119) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX | EPITOPE-SCAFFOLD FV COMPLEX, IMMUNE SYSTEM
4jpi:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4jpi:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4jpk:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | HIV-1 GP120, CD4 BINDING, VRC01-LIKE BROADLY NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1qok:A (VAL28) to (SER145) MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY | IMMUNOGLOBULIN, SINGLE-CHAIN FV, ANTI-CARCINOEMBRYONIC ANTIGEN
4ygv:A (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4ygv:F (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
3twc:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9 | FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM
4yhi:A (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhi:H (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhk:H (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhm:H (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhn:A (VAL2) to (SER118) DABIGATRAN REVERSAL AGENT | ANTIBODIES, IMMUNE SYSTEM
4yhn:F (VAL2) to (VAL117) DABIGATRAN REVERSAL AGENT | ANTIBODIES, IMMUNE SYSTEM
4yho:H (VAL2) to (SER118) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhp:C (GLN3) to (VAL119) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhp:H (GLN3) to (VAL119) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
1f11:B (VAL2) to (SER112) F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY | IMMUNOGLOBULIN, ANTIBODY, FAB, HEPATITIS B, PRES2, IMMUNE SYSTEM
1f11:D (VAL2) to (SER112) F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY | IMMUNOGLOBULIN, ANTIBODY, FAB, HEPATITIS B, PRES2, IMMUNE SYSTEM
4yhy:B (GLN3) to (VAL119) CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS | ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM
4yhy:H (GLN3) to (VAL119) CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS | ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM
2uud:J (VAL2) to (VAL111) CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN | SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4yjz:L (VAL202) to (VAL326) HUMAN ANTIBODY H2526 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006 | INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3u0t:D (GLN1) to (VAL110) FAB-ANTIBODY COMPLEX | ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM
3u0t:B (GLN1) to (VAL110) FAB-ANTIBODY COMPLEX | ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM
3u30:F (GLN3) to (VAL111) CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN | IMMUNE SYSTEM
3hae:T (VAL2) to (VAL117) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1qyg:H (THR3) to (VAL111) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
3hc4:H (VAL2) to (SER115) BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR | IGG1 FAB, BHA10, IMMUNE SYSTEM
3u7w:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF NIH45-46 FAB | IG FOLD, ANTIBODY, HIV GP120, IMMUNE SYSTEM
3u7y:H (VAL2) to (SER116) STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV | IG FOLD, GP120, ANTI HIV, GLYCOSYLATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3u7y:L (VAL3) to (VAL100) STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV | IG FOLD, GP120, ANTI HIV, GLYCOSYLATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4jzn:C (VAL2) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzn:I (GLN1) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:A (VAL2) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:C (VAL2) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:D (VAL2) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:G (VAL2) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1r3i:H (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+ | MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, RUBIDIUM
1r3j:B (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+ | MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM
1r3k:B (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+ | MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM
2eiz:B (GLN1) to (SER113) CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX | ANTIBODY, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX
3ubx:H (ILE2) to (SER119) CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX | IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM
3ubx:G (ILE2) to (SER119) CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX | IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM
1fj1:B (ILE2) to (SER112) LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2 | OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM
1fj1:D (GLN3) to (SER112) LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2 | OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM
4k3j:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA | ANTIBODY, GLYCOSYLATION, TRANSFERASE-IMMUNE SYSTEM-GROWTH FACTOR COMPLEX
2v7h:H (ALA2) to (SER120) CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT | MONOCLONAL ANTIBODY, MANNOPYRANOSIDE SPECIFICITY, MOLECULAR MIMICRY, IMMUNE SYSTEM
1rfd:H (VAL2) to (VAL111) ANTI-COCAINE ANTIBODY M82G2 | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
4k7p:H (ILE2) to (SER112) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
4k94:H (GLU1) to (SER116) CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODY FAB19 | RECEPTOR TYROSINE KINASE (RTK), FAB, IG SF, IMMUNE SYSTEM
1riv:H (THR3) to (VAL111) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
3uls:B (GLN1) to (THR119) CRYSTAL STRUCTURE OF FAB12 | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulu:F (VAL2) to (SER118) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:D (GLN1) to (VAL120) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:F (GLN1) to (SER118) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
4yxk:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB | PRION, ANTIBODY, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM
4yxl:H (GLN1) to (SER118) CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB | PRION, ANTIBODY, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM
4z0b:H (GLN1) to (THR120) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OFLOXACIN ANTIBODY AND EXPLORATION ITS RECEPTOR BINDING SITE | OFLOXACIN ELISA FAB, IMMUNE SYSTEM
4z0x:B (VAL27) to (SER143) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 434-446 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC26AM | HCV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
3hns:H (VAL2) to (SER117) CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE | ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM
3hnt:H (VAL2) to (SER117) CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN | ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM
3hnv:H (VAL2) to (SER117) CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE) | ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM
2vdq:H (VAL2) to (SER118) INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX
4kht:H (GLN3) to (VAL118) TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066 | GP41 FAB IMMUNE SYSTEM, IMMUNE SYSTEM
4khx:H (GLN3) to (SER119) CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062 | IMMUNE SYSTEM, GP41
1rz7:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:F (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:L (VAL2) to (ALA112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:P (GLN1) to (ALA112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1gaf:H (GLN3) to (SER113) 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID | ESTER HYDROLYSIS, ESTEROLYTIC, FAB, CATALYTIC ANTIBODY
3hr5:H (GLN3) to (SER116) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
3uyp:A (LEU4) to (SER116) CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 | DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM
3uzq:A (LEU4) to (VAL115) CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 | DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM
3uzv:B (LEU4) to (SER116) CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 | DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM
1s5h:B (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+ | K+ CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, SELECTIVITY FILTER, ION OCCUPANCY, MEMBRANE PROTEIN
3v0v:A (VAL2) to (SER112) FAB WN1 222-5 UNLIGANDED | BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM
2vl5:C (VAL2) to (SER118) STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1 | RHEUMATOID FACTOR, IMMUNE SYSTEM, ARTHRITIS, AUTOANTIBODIES, COLLAGEN TYPE II
2vlk:D (GLN3) to (PRO111) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2fx8:K (GLN1) to (SER112) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2fx9:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2fx9:I (GLN1) to (SER112) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
3v6o:D (VAL4) to (VAL117) LEPTIN RECEPTOR-ANTIBODY COMPLEX | RECEPTOR-ANTIBODY COMPLEX, CYTOKINE RECEPTOR, ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, LEPTIN RECEPTOR-ANTIBODY COMPLEX, IMMUNE SYSTEM
3i2c:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088 | IL-23, ANTIBODY, FAB, IMMUNE SYSTEM
2g5b:F (VAL2) to (VAL109) CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE. | 6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS
2g60:H (VAL2) to (SER112) STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN | ANTIBODY, FAB DOMAIN, ANTI-FLAG, IMMUNE SYSTEM
2vwe:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM, GLYCOPROTEIN, CYSTEINE-KNOT, GROWTH FACTOR, VEGF-B, MITOGEN, SECRETED, ANGIOGENESIS, NEUTRALIZING ANTIBODY, HEPARIN-BINDING, ALTERNATIVE SPLICING
2gcy:B (VAL2) to (VAL116) HUMANIZED ANTIBODY C25 FAB FRAGMENT | ANTIBODY FRAGMENT MOUSE HUMANIZED, IMMUNE SYSTEM
1svz:A (VAL129) to (SER247) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE | ANTIBODY-ANTIGEN COMPLEX; HIV INHIBITING ANTIBODY, IMMUNE SYSTEM
1sy6:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT | CD3 GAMMA, CD3 EPSILON, OKT3 FAB, SIGNALING PROTEIN/ANTIBIOTIC COMPLEX
1t04:B (VAL2) to (SER116) THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP | ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, THREE-DIMENSIONAL STRUCTURE, GAMMA- INTERFERON, IMMUNE SYSTEM
3vi4:H (VAL2) to (VAL116) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
3vi4:F (VAL2) to (VAL116) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
3idx:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3if1:D (VAL2) to (VAL111) CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC | GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM
3iga:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+ | KCSA, LITHIUM, LITHIUM BLOCK, POTASSIUM CHANNEL, MEMBRANE PROTEIN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, TRANSPORT PROTEIN
3ijs:D (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH TSBP | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijy:B (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
1h8n:A (VAL133) to (SER242) THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT FROM PHAGE-DISPLAYED MURINE ANTIBODY LIBRARIES | ANTIBODY, FRAMEWORK
3ikc:B (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
4zso:B (VAL2) to (SER120) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY | TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM
4lex:H (GLU1) to (VAL115) UNLIGANDED CRYSTAL STRUCTURE OF MAB7 | FAB FRAGMENT, ANTI-GCGR, FAB HEAVY AND LIGHT CHAIN, ANTIBODY, IMMUNE SYSTEM
3inu:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY. | ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3inu:M (GLN3) to (SER112) CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY. | ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3ivk:H (GLN6) to (SER124) CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT | CATALYTIC RNA, PROTEIN RNA COMPLEX, RNA POLYMERASE RIBOZYME, RNA HAIRPIN EPITOPE, IMMUNE SYSTEM - RNA COMPLEX
3ivk:A (GLN6) to (SER124) CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT | CATALYTIC RNA, PROTEIN RNA COMPLEX, RNA POLYMERASE RIBOZYME, RNA HAIRPIN EPITOPE, IMMUNE SYSTEM - RNA COMPLEX
2hfe:A (GLN3) to (SER117) RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER | CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN
2hfg:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB | FAB FRAGMENT, TNFRSF, ANTIBODY-RECEPTOR COMPLEX, CRD, IMMUNE SYSTEM
2hg5:A (GLN3) to (SER117) CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER | CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN
3iy3:B (ILE115) to (SER232) VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX | CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM
4llv:E (GLN1) to (SER112) THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV | 4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM
4llv:H (VAL2) to (SER112) THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV | 4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM
4llw:C (VAL2) to (SER118) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE DOMAIN REDESIGN (VRD2) AT 1.95A | FAB, IMMUNE SYSTEM
2hjf:A (GLN3) to (VAL116) POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA) | POTASSIUM CHANNEL, ION TRANSPORT, METAL TRANSPORT
3vw3:H (VAL2) to (SER112) ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT | PROTEIN-DNA COMPLEX, DNA (6-4) PHOTOPRODUCT, IMMUNOGLOBULIN, IMMUNE SYSTEM-DNA COMPLEX
4lrn:H (GLN3) to (SER112) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV ANTIBODY 4E10 | GERMLINE, HIV, IMMUNOGLOBULIN, FV PORTION OF AB, 4E10 EPITOPE, IMMUNE SYSTEM
1i3g:H (VAL2) to (SER148) CRYSTAL STRUCTURE OF AN AMPICILLIN SINGLE CHAIN FV, FORM 1, FREE | ANTIBODY FV FRAGMENT, ANTIBIOTIC
4lsp:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 | NEUTRALIZING ANTIBODY VRC-CH31, HIV ENVELOPE GLYCOPROTEIN GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4lsq:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1 | NEUTRALIZING ANTIBODY VRC-CH31, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4lss:H (VAL2) to (SER113) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120 | ANTIBODY ANTIGEN COMPLEX, NEUTRALIZING ANTIBODY VRC01, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4lst:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120 | NEUTRALIZING ANTIBODY VRC01, HIV ENVELOPE GLYCOPROTEIN GP120, ANTIBODY ANTIGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4lsu:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | NEUTRALIZING ANTIBODY VRC-PG20, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5a2j:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH THE NAKED PEPTIDE APDTRP | PEPTIDE BINDING PROTEIN, GLYCOPEPTIDES, ANTIBODIES, MOLECULAR RECOGNITION, CONFORMATION ANALYSIS, FUSION PROTEIN
5a2l:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-CGALNAC-RP | IMMUNE SYSTEM, PEPTIDE BINDING PROTEIN, GLYCOPEPTIDES, ANTIBODIES, MOLECULAR RECOGNITION, CONFORMATION ANALYSIS, FUSION PROTEIN
3w14:C (VAL2) to (VAL111) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
3w14:P (VAL2) to (VAL111) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
2hvk:A (GLN3) to (SER117) CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
2hvj:A (GLN3) to (SER117) CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
4m1g:H (VAL2) to (SER117) STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
1igt:D (VAL2) to (SER112) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN
1uj3:B (VAL302) to (SER416) CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR | TISSUE FACTOR, ANTIGEN, ANTIBODY, FAB, IMMUNE SYSTEM/BLOOD CLOTTING COMPLEX
5a7x:N (GLN1) to (SER112) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:P (GLN1) to (SER112) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:R (GLN1) to (SER112) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a8h:F (GLN1) to (SER112) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:L (GLN1) to (SER112) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:R (GLN1) to (SER112) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
1ind:H (GLU1) to (VAL112) HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE | IMMUNOGLOBULIN
2i9l:B (VAL2) to (SER118) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2i9l:D (VAL2) to (SER118) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2i9l:F (VAL2) to (SER118) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2i9l:H (VAL2) to (SER118) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
4m61:D (ILE2) to (SER119) CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4m7k:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10 | ANTIBODY, IMMUNE SYSTEM
4m8q:H (GLN1) to (SER112) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10 | HIV, 4E10, GEP, GERMLINE, FV, IMMUNOGLOBULIN, ANTIBODY, 4E10 EPITOPE, IMMUNE SYSTEM
4ma7:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE | IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM
4ma8:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE | IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM
2ih1:A (GLN3) to (SER117) ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION | ION CHANNEL D-AMINO ACID SEMI-SYNTHETIC, MEMBRANE PROTEIN
1uwx:H (VAL2) to (VAL111) P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT | IMMUNE SYSTEM, ANTIBODY/COMPLEX, FAB, IMMUNOGLOBULIN, PROTEIN G, PORA, ANTIBODY, IGB
1uwx:M (VAL2) to (VAL111) P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT | IMMUNE SYSTEM, ANTIBODY/COMPLEX, FAB, IMMUNOGLOBULIN, PROTEIN G, PORA, ANTIBODY, IGB
1j05:B (VAL2) to (SER112) THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT | IMMUNOGLOBULIN, IMMUNE SYSTEM
1uyw:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2 | IMMUNE SYSTEM
1uyw:M (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2 | IMMUNE SYSTEM
3wih:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A. | FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM
3wih:I (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A. | FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM
4mhh:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1) | H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhh:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1) | H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3wlw:H (VAL2) to (SER116) MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER | HYDROLASE-IMMUNE SYSTEM COMPLEX
1v7n:K (LYS3) to (SER115) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
4msw:A (GLN3) to (SER117) Y78 ESTER MUTANT OF KCSA IN HIGH K+ | MEMBRANE PROTEIN, CHANNEL, ESTER, UNNATURAL AMINO ACID, TRANSPORT PROTEIN
1jp5:A (VAL129) to (SER246) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE | ANTIBODY-ANTIGEN COMPLEX, HIV PR INHIBITING ANTIBODY, IMMUNE SYSTEM
1jp5:B (VAL129) to (SER246) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE | ANTIBODY-ANTIGEN COMPLEX, HIV PR INHIBITING ANTIBODY, IMMUNE SYSTEM
1jpt:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF FAB D3H44 | ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, CRYSTAL STRUCTURE, IMMUNE SYSTEM
3j70:A (VAL2) to (SER112) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j70:M (VAL2) to (SER112) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j70:R (VAL2) to (SER112) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mxv:H (VAL2) to (SER112) STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
5az2:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN | ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, IMMUNE SYSTEM
3j8v:H (GLN3) to (SER112) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:F (GLN3) to (SER112) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:G (GLN3) to (SER112) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:I (GLN3) to (SER112) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j93:H (VAL2) to (SER118) FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12 | FAB, EV71, FAB22A12, IMMUNE SYSTEM
2xqy:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ENVELOPE PROTEIN
2jel:H (VAL2) to (SER112) JEL42 FAB/HPR COMPLEX | ANTIBODY-PROTEIN COMPLEX, HISTIDINE-CONTAINING PROTEIN, MOLECULAR RECOGNITION, COMPLEX (ANTIBODY/ANTIGEN)
3jab:H (VAL2) to (SER112) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX
3jab:Q (VAL2) to (SER112) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX
4n8c:H (VAL2) to (VAL117) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
4n8c:I (VAL2) to (SER118) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
4n9g:M (VAL2) to (SER124) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
1k4d:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+ | K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
1k6q:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3 | ANTIGEN-ANTIBODY RECOGNITION, CRYSTAL STRUCTURE, BLOOD COAGULATION, TISSUE FACTOR, IMMUNE SYSTEM
2xzq:H (VAL2) to (SER119) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF | BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, IMMUNE SYSTEM
5bv7:H (GLN3) to (GLY117) CRYSTAL STRUCTURE OF HUMAN LCAT (L4F, N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY | A/B HYDROLASE, IMMUNE SYSTEM, HYDROLASE-IMMUNE SYSTEM COMPLEX
5bvj:D (VAL2) to (SER117) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
4ngh:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY. | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM
4nhc:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41. | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM
3zkn:C (GLN3) to (SER115) BACE2 FAB INHIBITOR COMPLEX | IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX
3zkn:H (GLN3) to (SER115) BACE2 FAB INHIBITOR COMPLEX | IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX
4nja:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS | IMMUNOGLOBULIN FOLD, MPTS BINDING, IMMUNE SYSTEM
4nkm:E (VAL2) to (VAL120) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkm:G (VAL2) to (VAL120) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
5c0n:H (GLN1) to (SER119) DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE | AP2, FABP4, FAB, TYPE II DIABETES, LIPID TRANSPORT
5c0n:C (GLN1) to (SER119) DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE | AP2, FABP4, FAB, TYPE II DIABETES, LIPID TRANSPORT
2y5t:A (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE | IMMUNE SYSTEM, ANTIBODY, RHEUMATOID ARTHRITIS, ARTHRITOGENIC
4nwu:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF APE1551, AN ANTI-HUMAN NGF FAB WITH A NINE AMINO ACID INSERTION IN CDR H1 | BETA-SANDWICH, HUMAN BETA NERVE GROWTH FACTOR, IMMUNE SYSTEM
4nyl:H (VAL2) to (VAL119) CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT | IMMUNOGLOBULIN FOLDING, ANTIBODY FRAGMENT, TNF ALPHA, IMMUNE SYSTEM
2nlj:B (GLN3) to (SER117) POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL | VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
1xf4:H (VAL2) to (SER112) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
2nr6:F (ILE2) to (SER115) CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2 | BLA G 2, FAB, HYDROLASE-IMMUNE SYSTEM COMPLEX
4ob5:H (VAL2) to (SER112) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE BROADLY NEUTRALIZING ANTI-HIV ANTIBODY 4E10 | IMMUNOGLOBULIN FOLD, ANTI-HIV ANTIBODY GERMLINE PRECURSOR, HIV GP41, IMMUNE SYSTEM
5cin:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
4ocm:C (GLN4) to (SER122) CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IB | 26S PROTEASOME, ISOPEPTIDASE ACTIVITY, REGULATORY PARTICLE, LID, UBIQUITIN, HYDROLASE, PROTEIN BINDING
4odw:H (VAL2) to (SER112) UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 | CARBOHYDRATE BINDING, IMMUNE SYSTEM
5cjo:H (GLN6) to (VAL130) CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN | HYDROLASE, FAB, ELBOW-ENGINEER, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1lk3:H (VAL2) to (SER118) ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM
1lk3:I (VAL2) to (SER118) ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM
5cjx:A (GLN1) to (SER112) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjx:D (GLN1) to (SER112) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjx:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4oii:H (VAL2) to (SER112) WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB | WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
4oii:I (VAL2) to (SER112) WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB | WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
4okv:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY | MALARIA VECTOR MOSQUITO, COLLAGEN BINDING PROTEIN, BLOOD CLOTTING
4olv:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54F, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1m7d:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE | FAB-CARBOHYDRATE INTERACTIONS, SHIGELLA O-ANTIGEN, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1m7i:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE | FAB-CARBOHYDRATE INTERACTIONS; SHIGELLA O-ANTIGEN; AND ANTI- CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
5czx:C (VAL2) to (SER118) CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB | ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM
5czx:H (GLN1) to (SER118) CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB | ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM
4oz4:H (VAL2) to (SER119) X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A. | FAB, APO-FORM, IMMUNE SYSTEM
4oz4:A (VAL2) to (SER119) X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A. | FAB, APO-FORM, IMMUNE SYSTEM
1mim:H (GLN1) to (SER114) IGG FAB FRAGMENT (CD25-BINDING) | IMMUNOGLOBULIN, C REGION
5d1z:D (GLN1) to (VAL126) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d2l:F (VAL4) to (LEU114) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
4ag4:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX | IMMUNE SYSTEM-TRANSFERASE COMPLEX
1mlc:B (VAL2) to (SER115) MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME | COMPLEX (ANTIBODY/ANTIGEN)
1moe:A (VAL121) to (SER239) THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE. | ANTI CARCINOEMBRYONIC ANTIGEN, T84.66, DIABODY, DIMER, SCFV, VARIABLE DOMAIN, IMMUNE SYSTEM
1moe:B (VAL121) to (VAL238) THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE. | ANTI CARCINOEMBRYONIC ANTIGEN, T84.66, DIABODY, DIMER, SCFV, VARIABLE DOMAIN, IMMUNE SYSTEM
35c8:H (GLN3) to (SER112) CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
1yei:H (MET2) to (SER112) CATALYTIC ANTIBODY D2.3 COMPLEX | CATALYTIC ANTIBODY D2.3 COMPLEX, IMMUNE SYSTEM
4pb0:H (VAL2) to (VAL111) STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53 | ANTIBODY, IMMUNE SYSTEM
5d96:C (GLN1) to (SER117) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1 | ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM
1yjd:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1) | IGSF, CD28 HOMODIMER, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5dd1:H (GLN1) to (SER112) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3kym:J (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
4pgj:C (GLN3) to (SER120) HUMAN HEAVY-CHAIN DOMAIN ANTIBODY IN COMPLEX WITH HEN EGG-WHITE LYSOZYME | ANTIBODY HUMAN DAB CLEFT BINDER DAB-HEL COMPLEX, IMMUNE SYSTEM- HYDROLASE COMPLEX
1yuh:B (VAL2) to (SER117) FAB FRAGMENT | ANTI-NITROPHENOL, LAMBDA LIGHT CHAIN, IMMUNOGLOBULIN, IMMUNE SYSTEM
1yy8:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225 | FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM
1yy8:D (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225 | FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM
1yy9:D (GLN3) to (SER118) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225 | CELL SURFACE RECEPTOR; TYROSINE KINASE; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4plj:H (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX
4plj:D (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX
3l95:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY | NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM
5do2:C (VAL2) to (VAL114) COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY | RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ld8:C (GLN1) to (SER117) STRUCTURE OF JMJD6 AND FAB FRAGMENTS | JMJD6, FAB FRAGMENTS, IMMUNE SYSTEM
3lh2:I (VAL2) to (GLN119) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
3lh2:J (VAL2) to (GLN119) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
1za6:H (VAL2) to (VAL113) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
5dsc:E (GLN3) to (SER112) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM
5e1a:A (GLN3) to (SER117) STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS | KCSA, MUTATION, PROTONS, POTASSIUM CHANNELS, METAL TRANSPORT
1ztx:H (VAL2) to (SER112) WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB | ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1zwi:A (GLN3) to (SER117) STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL | X-RAY CRYSTALLOGRAPHY; POTASSIUM ION CHANNEL; TRANSMEMBRANE PROTEIN, IMMUNE SYSTEM-ION TRANSPORT COMPLEX
4q6i:B (GLN1) to (SER112) CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4 | IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM
4q6i:E (GLN1) to (SER112) CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4 | IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM
4q6i:G (GLN1) to (SER112) CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4 | IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM
4q6i:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4 | IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM
25c8:H (GLN3) to (SER112) CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
5e8d:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5 | ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, CANCER, IMMUNE SYSTEM
5ea0:H (VAL2) to (SER114) STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE | COMPLEMENT FACTOR H CFH SCR19 SCR19-20, IMMUNE SYSTEM
5ebl:A (GLN3) to (SER117) KCSA T75G IN THE CONDUCTIVE STATE | ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL
5ebm:A (GLN3) to (SER117) KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE | ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL
4qex:H (VAL2) to (SER111) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
4qex:I (VAL2) to (SER111) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
5ec1:A (GLN3) to (SER117) KCSA WITH V76ESTER MUTATION | ALPHA HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN
5ec2:A (GLN3) to (SER117) KCSA WITH V76ESTER+G77DA MUTATIONS | ALPHA-HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN
3b2u:W (VAL2) to (SER120) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2v:H (GLN1) to (SER120) CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4qhn:A (VAL2) to (VAL111) I2 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3ma9:H (GLN3) to (SER119) CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066 | GP41, IMMUNE SYSTEM
3mcl:H (VAL2) to (SER118) ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2aep:H (VAL2) to (VAL111) AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. | INFLUENZA VIRUS NEURAMINIDASE-FAB COMPLEX, IMMUNE SYSTEM
3b9v:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN | ANTIBODY ENGINEERING, PHAGE DISPLAY, IMMUNE SYSTEM
3bae:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
3mj8:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS | ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM
3mj8:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS | ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM
3mj9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10 | IMMUNOGLOBULIN TANDEM DOMAIN, RECEPTOR-ANTIBODY COMPLEX, CELL ADHESION, CELL JUNCTION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, COSTIMULATION, HAMSTER IGG, TRANSMEMBRANE, IMMUNE SYSTEM
5epm:E (VAL2) to (SER118) CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT | CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX
3mlu:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3bgf:H (GLU1) to (SER112) X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB | ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
3bgf:B (VAL2) to (VAL111) X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB | ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
4qt5:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR | GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM
4qt5:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR | GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM
5etu:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5etu:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5euo:E (LEU4) to (LYS113) PF6-M1-HLA-A2 | TCR, FLU, MHC, IMMUNE SYSTEM
4bkl:A (VAL2) to (SER115) CRYSTAL STRUCTURE OF THE ARTHRITOGENIC ANTIBODY M2139 (FAB FRAGMENT) IN COMPLEX WITH THE TRIPLE-HELICAL J1 PEPTIDE | IMMUNE SYSTEM, ANTIBODY, RHEUMATOID ARTHRITIS, COLLAGEN TYPE II
3bqu:D (VAL2) to (SER121) CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX | BETA SHEET, IMMUNE SYSTEM
4qxg:H (VAL2) to (SER116) ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY | IGV AND IGC TYPE FOLDS, ANTIGEN BINDING, IFNAR1, INTERFERON ALPHA RECEPTOR 1, IMMUNE SYSTEM
3bt2:H (LYS3) to (SER112) STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX | PROTEIN-PROTEIN INTERACTION, GLYCOPROTEIN, GPI-ANCHOR, LIPOPROTEIN, MEMBRANE, RECEPTOR, SECRETED, BLOOD COAGULATION, EGF-LIKE DOMAIN, FIBRINOLYSIS, HYDROLASE, KRINGLE, PHOSPHOPROTEIN, PLASMINOGEN ACTIVATION, PROTEASE, SERINE PROTEASE, ZYMOGEN, CELL ADHESION, HEPARIN-BINDING, SULFATION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5f45:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF FAB H7.167 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/SHANGHAI/02/2013 (H7N9) | HEMAGGLUTININ, RECEPTOR-BINDING SITE, HUMAN ANTIBODY, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3mxw:H (VAL2) to (SER112) CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT | ANTIBODY COMPLEX, FAB FRAGMENT, METALLOPROTEASE, CALCIUM BINDING, ZINC HYDROLASE, DEVELOPMENT, MORPHOGEN, SIGNALING PROTEIN
5f88:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5f88:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3bz4:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE | O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM
5ff6:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5ff6:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4r4n:N (GLN1) to (SER112) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120 | HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
5fha:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114 | IG DOMAIN, FAB, IMMUNE SYSTEM
5fhb:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100 | IG DOMAIN, FAB, IMMUNE SYSTEM
5fhc:A (GLN1) to (VAL111) CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP) | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5fhc:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP) | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5fhx:H (VAL2) to (GLY114) CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBULIN MULTIFUNCTIONAL BIOTHERAPEUTIC DRUG, CODV, IMMUNE SYSTEM
3n85:H (VAL2) to (VAL110) CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT | HER2, ERBB2, TRP/SER LIBRARY, PHAGE DISPLAY, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4r7d:O (VAL2) to (VAL116) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:A (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:C (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:G (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:M (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4rau:B (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:E (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:H (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:K (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:N (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:Q (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:T (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rau:W (VAL4) to (SER120) CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4 | RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM
4rdq:G (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:I (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:K (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:M (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:O (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
3ncy:P (VAL2) to (SER119) X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT | MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN
3nfp:A (VAL2) to (SER115) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
3nfp:H (VAL2) to (SER115) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
4rfe:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
3ngb:H (VAL2) to (SER113) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ngb:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ngb:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ngb:J (VAL2) to (SER113) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3cle:H (ALA2) to (SER112) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3cmo:H (VAL2) to (SER112) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3nn8:A (VAL2) to (SER121) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
4cad:B (VAL2) to (SER124) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:H (VAL2) to (SER124) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:K (VAL2) to (SER124) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cc8:F (VAL2) to (SER112) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:H (VAL2) to (SER112) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:I (VAL2) to (SER112) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
5fuu:H (GLN3) to (SER112) ECTODOMAIN OF CLEAVED WILD TYPE JR-FL ENVDCT TRIMER IN COMPLEX WITH PGT151 FAB | VIRAL PROTEIN, HIV-1, ENV, PGT151, BROADLY NEUTRALIZING ANTIBODY
4rrp:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
4rrp:K (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
3nz8:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8 | ANTIGEN BINDING, ANTIBODY, FAB, IMMUNOLOGICAL, HIV-2, V3, GP125, IMMUNE SYSTEM
3cvh:H (VAL1) to (SER119) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3cvh:Q (VAL1) to (VAL118) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3cvi:H (VAL1) to (SER119) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | FAB, IMMUNE SYSTEM
4cni:A (VAL2) to (SER119) CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6 | IMMUNE SYSTEM, CDP6038, INTERLEUKIN 6
4s11:A (VAL2) to (SER126) GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS | NANOBODY, IMMUNE SYSTEM
4s1s:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H5.F-185917, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
3d85:B (VAL2) to (SER114) CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB | INTERLEUKIN-23, FAB, IMMUNE SYSTEM/CYTOKINE COMPLEX
3of6:B (VAL4) to (GLU118) HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE | IG FOLD, IMMUNE SYSTEM
5ggu:H (GLN3) to (VAL123) CRYSTAL STRUCTURE OF TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ghw:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND | BROAD NEUTRALIZING ANTIBODY, RECOMBINANT FAB, EPITOPE, IMMUNE SYSTEM, HIV-1, VIRAL MEMBRANE
3ojd:B (LYS3) to (SER112) ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT) | BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, ANTI-INDOLICIDIN FAB, SURROGATE RECEPTOR, IMMUNE SYSTEM
3okd:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3oko:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
5grz:G (GLN3) to (SER118) CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY | DIABODY, ANTIBODY FRAGMENT, DISULFIDE BOND, IMMUNE SYSTEM
3oz9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1 | IMMUNOGLOBULIN FOLD, NON-NEUTRALIZING ANTIBODY, HIV-1 GP41 6-HELIX BUNDLE CORE, IMMUNE SYSTEM
4dgi:H (VAL2) to (SER118) STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230 | PRION, ANTIBODY, PROTEIN BINDING
3p0v:H (GLN3) to (SER112) ANTI-EGFR/HER3 FAB DL11 ALONE | BETA-SANDWICH, IMMUNE SYSTEM, ANTIGENS EGFR AND HER3
3p0y:H (VAL2) to (SER112) ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION | BETA-SANDWICH, ANTIGENS EGFR, IMMUNE SYSTEM
4u6h:A (VAL2) to (SER118) VACCINIA L1/M12B9-FAB COMPLEX | IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN
4u6h:C (VAL2) to (SER118) VACCINIA L1/M12B9-FAB COMPLEX | IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN
5hpm:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5hyq:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5hyq:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5i0z:A (VAL24) to (VAL140) CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH | 3D8 SCFV, 3D8-VH, IMMUNE SYSTEM
5i1e:H (GLN3) to (VAL116) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i2i:B (VAL2) to (SER118) STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE | IMMUNE SYSTEM, ANTIBODY
5i2i:D (VAL2) to (SER118) STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE | IMMUNE SYSTEM, ANTIBODY
4dvr:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD- 557 | HIV-1 GP120, CD4 BINDING SITE, NBD-557, IMMUNE SYSTEM-TRANSCRIPTION INHIBITOR COMPLEX
3phq:B (VAL2) to (SER115) CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, CARBOHYDRATE-BINDING PROTEIN
4uik:H (VAL2) to (SER121) CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1 | IMMUNE SYSTEM, QUININE-DEPENDENT, MOUSE MAB
5i5k:X (VAL2) to (VAL120) STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB | COMPLEMENT, FAB, IMMUNE SYSTEM
5i66:A (VAL21) to (SER137) X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4uom:H (GLN3) to (VAL114) ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB F5 | VIRAL PROTEIN, ALPHAVIRUS, VENEZUELAN, ANTIBODY NEUTRALIZATION, FAB
3pnw:B (VAL5) to (VAL127) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:E (VAL5) to (SER128) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:H (VAL5) to (SER128) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
5i6x:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i6z:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER | MEMBRANE PROTEIN
5i71:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i73:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES | MEMBRANE PROTEIN
5i75:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE | MEMBRANE PROTEIN
5i8c:A (GLU2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8h:E (GLU2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8h:G (GLU2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i9q:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
3pp4:H (VAL2) to (SER118) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB FRAGMENT IG-DOMAIN, CD20, CYCLIC PEPTIDE, ANTIBODY ANTIGEN, IMMUNE SYSTEM
5icy:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5icy:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5icx:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5icx:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5icz:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5id1:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5id1:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5ies:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A | HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
5if0:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A | HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
5if0:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A | HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
5ifa:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF UNBOUND VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR AT 1.82 A | VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, CD4 BINDING SITE, IMMUNE SYSTEM, ANTI-HIV-1
4ut7:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, SCFV FRAGMENT
4utb:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT
4utb:I (GLN3) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT
4uu9:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HUMAN C5A IN COMPLEX WITH MEDI7814 A NEUTRALISING ANTIBODY | IMMUNE SYSTEM, FV, COMPLEMENT SYSTEM
4uuj:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM | IMMUNE SYSTEM-METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL
4ebq:H (VAL3) to (SER119) FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, VACCINIA VIRUS, D8L ENVELOPE PROTEIN, CONFORMATIONAL EPITOPE, DISCONTINUOUS EPITOPE, D8L ANTIGEN BINDING, NEUTRALIZING MAB IN PRESENCE OF COMPLEMENT, D8L VACCINIA ENVELOPE PROTEIN, PAPAIN TREATMENT, IMMUNE SYSTEM
5ikc:B (VAL2) to (SER114) X-RAY STRUCURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB | DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE
4ei5:D (VAL4) to (LEU114) CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1 | SULFATIDE, LIPID, CD1D, NKT TYPEII, TCR, IMMUNE SYSTEM
4ei6:B (VAL4) to (GLU115) STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR | NATURAL KILLER T CELL RECEPTOR, IMMUNE SYSTEM
5iop:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5iop:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5ir1:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5ir1:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3q3g:D (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3q3g:B (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3q3g:H (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3q3g:K (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
5iv2:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT | IMMUNE SYSTEM
5iv2:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT | IMMUNE SYSTEM
4etq:H (GLN4) to (SER119) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4etq:A (VAL3) to (SER119) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3qa3:D (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM- CELL ADHESION COMPLEX
3qa3:B (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM- CELL ADHESION COMPLEX
3qa3:H (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM- CELL ADHESION COMPLEX
3qa3:K (GLN5) to (SER123) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM- CELL ADHESION COMPLEX
4evn:A (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:C (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:E (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:G (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:I (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:K (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:M (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:O (GLN1) to (SER116) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4f3f:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX | ANTIBODY FAB, RECOGNIZE MESOTHELIN, MESOTHELIN, IMMUNE SYSTEM
4f57:H (VAL2) to (SER112) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
3qib:D (VAL4) to (GLU115) CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK | IG DOMAIN, IMMUNE SYSTEM
3qpq:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qpq:D (VAL2) to (SER118) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qrg:H (ILE2) to (VAL118) CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M | FAB STRUCTURE, RSV, IMMUNE SYSTEM
3qum:B (VAL2) to (VAL112) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY | KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM
4ffv:D (PHE2) to (SER116) CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB | HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX
4ffv:H (PHE2) to (SER116) CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB | HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX
4ffw:H (PHE2) to (SER116) CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN | HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX
5j9p:A (GLN3) to (SER117) KCSA IN VITRO | MEMBRANE PROTEIN, ION CHANNEL, IN VITRO, METAL TRANSPORT
3ra7:H (VAL2) to (VAL123) BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY | FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM
3ra7:I (VAL2) to (VAL123) BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY | FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM
5jhl:H (GLN8) to (ALA121) CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY | ZIKA VIRUS, ENVELOPE PROTEIN, FLAVIVIRUS, BROADLY-PROTECTIVE ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqi:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H5N1 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqv:J (GLN1) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqy:H (GLN1) to (VAL111) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5jof:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT. | HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM
3ria:F (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:G (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:H (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:I (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:J (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
5jw3:H (GLN3) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H7 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jxa:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT. | HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM
4g7v:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4glr:H (VAL2) to (VAL111) STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235 | IGG1 FAB, ANTI-PTAU ANTIBODY, PHOSPHORYLATED TAU PEPTIDE, PHOSPHORYLATION, IMMUNE SYSTEM
4glr:J (VAL2) to (VAL111) STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235 | IGG1 FAB, ANTI-PTAU ANTIBODY, PHOSPHORYLATED TAU PEPTIDE, PHOSPHORYLATION, IMMUNE SYSTEM
4gms:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gms:I (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gms:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gmt:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 | FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
5l2k:D (ASN3) to (GLN130) CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX | CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, GEM42, IMMUNE SYSTEM
5lcv:H (GLN3) to (VAL111) STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5sx4:J (GLN1) to (VAL117) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
5sx4:H (GLN1) to (VAL117) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
5sx5:J (GLN1) to (VAL117) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
5sx5:H (GLN1) to (VAL117) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
5t1k:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t1k:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t1l:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t1l:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t1m:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t1m:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t5n:G (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:I (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:K (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:M (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:O (VAL2) to (SER115) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5te6:H (ALA2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE | HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM
5te7:H (ALA2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE C STRAIN DU172.17 GP120 CORE | HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM
5tgb:H (VAL2) to (SER112) STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM
5tgb:A (VAL2) to (SER112) STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM
7fab:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, IMMUNE SYSTEM
1n7m:L (VAL2) to (SER113) GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN | IMMUNE SYSTEM
2ai0:H (VAL2) to (ALA121) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III | IMMUNE SYSTEM
2aj3:F (VAL2) to (VAL111) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
4gw1:B (VAL2) to (SER118) CQFD MEDITOPE | IGG, IMMUNE SYSTEM, EGFR
4gw1:D (VAL2) to (SER118) CQFD MEDITOPE | IGG, IMMUNE SYSTEM, EGFR
1ad0:D (VAL2) to (VAL111) FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7 | IMMUNOGLOBULIN, FAB FRAGMENT
2atk:A (GLN3) to (SER117) STRUCTURE OF A MUTANT KCSA K+ CHANNEL | K+ CHANNEL, MUTANT KCSA, PROTEIN-ANTIBODY FAB COMPLEX, IMMUNE SYSTEM- ION TRANSPORT COMPLEX
1ar1:C (VAL2) to (VAL116) STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT | COMPLEX (OXIDOREDUCTASE/ANTIBODY), ELECTRON TRANSPORT, TRANSMEMBRANE, CYTOCHROME OXIDASE, ANTIBODY COMPLEX
2bdn:H (VAL2) to (VAL115) CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY, 11K2 | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4hg4:R (GLU1) to (SER112) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3f7v:A (GLN3) to (VAL116) KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112 | KCSA, POTASSIUM CHANNEL, INACTIVATION, OPEN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
1bvl:A (VAL2) to (SER115) HUMANIZED ANTI-LYSOZYME FV | HUMANIZED ANTIBODY, FV, ANTI-LYSOZYME
3fb5:A (GLN3) to (VAL116) KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112 | KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
3fb7:A (GLN3) to (VAL116) OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION | KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
4xcy:C (GLN1) to (GLN105) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG) | 4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL
4xcy:G (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG) | 4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL
1c5d:B (LYS3) to (SER116) THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | IMMUNOGLOBULIN, IMMUNE SYSTEM
4xh2:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
1ce1:H (VAL2) to (VAL119) 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN | THERAPEUTIC, ANTIBODY, CD52, IMMUNE SYSTEM
1clo:H (VAL2) to (VAL111) ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 | IMMUNOGLOBULIN, FAB-FRAGMENT
4xpa:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3, 4DICHLOROPHENETHYLAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX
1pg7:H (VAL2) to (SER112) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
1pg7:I (VAL2) to (SER112) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
1pg7:Z (VAL2) to (SER112) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
1pkq:B (VAL2) to (VAL111) MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX | AUTOANTIBODY, MULTIPLE SCLEROSIS, EAE, IMMUNE SYSTEM
1pkq:G (VAL2) to (VAL111) MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX | AUTOANTIBODY, MULTIPLE SCLEROSIS, EAE, IMMUNE SYSTEM
3gjf:L (LEU4) to (VAL108) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
2r23:B (VAL2) to (VAL109) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
2ddq:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT | MONOCLONAL ANTIBODY, 4-HYDROXY-2-NONENAL, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q0y:H (VAL2) to (SER112) ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE | ANTI-MORPHINE ANTIBODY, FAB, IMMUNE SYSTEM
4j6r:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, CD4-BINDING SITE, VRC23, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ybq:D (VAL3) to (SER119) RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM | SUGAR TRANSPORTER, MAJOR FACILITATOR SUPERFAMILY, TRANSPORT PROTEIN- IMMUNE SYSTEM COMPLEX
4ybq:F (VAL3) to (SER119) RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM | SUGAR TRANSPORTER, MAJOR FACILITATOR SUPERFAMILY, TRANSPORT PROTEIN- IMMUNE SYSTEM COMPLEX
1r3l:B (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+ | MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, CESIUM
3u9p:K (VAL2) to (SER118) CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT | BETA BARREL, TRANSPORT PROTEIN, IMMUNE SYSTEM
1for:H (GLY2) to (SER118) STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX | IMMUNOGLOBULIN
1riu:H (THR3) to (SER112) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
1rjl:B (VAL2) to (SER119) STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831 | BETA SHEET, ANTIBODY-PROTEIN COMPLEX, IMMUNE SYSTEM
4ki5:E (VAL2) to (SER121) CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99 | IMMUNOGLOBULIN FOLD, DISCOIDIN FOLD, ANTIBODY, BLOOD COAGULATION FACTOR, ANTIGEN BINDING, BLOOD PLASMA, IMMUNE SYSTEM
2vh5:H (VAL2) to (SER114) CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX | IMMUNOGLOBULIN DOMAIN, SIGNALING PROTEIN/IMMUNE SYSTEM, METHYLATION, PRENYLATION, LIPOPROTEIN, GTP-BINDING, SIGNAL TRANSDUCTION, NUCLEOTIDE- BINDING, DISEASE MUTATION, NUCLEOTIDE-BINDING, IMMUNE SYSTEM, MEMBRANE, ONCOGENE, ANTIBODY, PALMITATE, INTRABODY, PROTO-ONCOGENE, CANCER THERAPY, GOLGI APPARATUS
3hpl:A (GLN3) to (SER117) KCSA E71H-F103A MUTANT IN THE CLOSED STATE | KCSA, E71H, F103A, CLOSED, INACTIVATION, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, IMMUNE SYSTEM-METAL TRANSPORT COMPLEX
3uze:A (LYS3) to (VAL115) CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 | DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM
3v0w:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS | BETA BARREL, ANTIBODY, FAB, IMMUNE SYSTEM
3v4v:H (GLN1) to (GLN113) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376 | CELL ADHESION, MADCAM-1, MEMBRANE
3v4v:M (GLN1) to (GLN113) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376 | CELL ADHESION, MADCAM-1, MEMBRANE
4kte:H (PCA1) to (THR110) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE148, FROM NON-HUMAN PRIMATE | ANTIBODY AFFINITY, ANTIBODY SPECIFICITY, VACCINE ELICITED ANTIBODIES, FAB FRAGMENT, AIDS VACCINES, IMMUNE SYSTEM
3i75:B (VAL2) to (SER124) ANTIBODY STRUCTURE | ANTIBODY, IGG, IMMUNE SYSTEM
3vi3:F (VAL2) to (VAL116) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM) | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
4lar:H (GLU1) to (VAL111) CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE | METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, SCFV, IMMUNE SYSTEM
1tjg:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE | 2F5; ANTIBODY; GP41; HIV-1; NEUTRALIZING; MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1hkl:H (GLN3) to (SER112) FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN
3iu3:C (GLN1) to (SER114) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
3iu3:H (GLN1) to (SER114) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
3iu4:H (GLN3) to (VAL111) ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3 | ANTIBODY, GANGLIOSIDE, IDIOTYPE, IMMUNE SYSTEM
4zyp:F (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
4zyp:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
3iy0:H (VAL2) to (ALA118) VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX | CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM
4llu:A (VAL2) to (SER112) STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A | FAB, IMMUNE SYSTEM
1i9r:H (VAL2) to (SER117) STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY | BETA-SHEET SANDWICH, IMMUNOGLOBULIN, CYTOKINE/IMMUNE SYSTEM COMPLEX
1i9r:X (VAL2) to (SER117) STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY | BETA-SHEET SANDWICH, IMMUNOGLOBULIN, CYTOKINE/IMMUNE SYSTEM COMPLEX
3whe:M (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:O (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:Q (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:S (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:U (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:W (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:Y (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:1 (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:3 (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:5 (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:7 (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3whe:9 (VAL2) to (SER125) A NEW CONSERVED NEUTRALIZING EPITOPE AT THE GLOBULAR HEAD OF HEMAGGLUTININ IN H3N2 INFLUENZA VIRUSES | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3wii:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1. | IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM
3wii:I (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1. | IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM
4mhj:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhj:F (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhj:K (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhj:T (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhj:R (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mhj:W (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2itd:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE | VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
3j3z:H (VAL2) to (SER118) STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT | EV71, ENTEROVIRUS, HFMD, STRAIN-SPECIFIC EPTITOPE, VP1-145, IMMUNE SYSTEM
2jix:D (GLN1) to (SER115) CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR | IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX
5chn:H (VAL2) to (SER121) FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16 | ANTIBODY, IMMUNE SYSTEM
5chn:A (VAL2) to (SER121) FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16 | ANTIBODY, IMMUNE SYSTEM
2zck:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA, A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY | HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM
4ouo:A (VAL116) to (VAL231) ANTI-BLA G 1 SCFV | COCKROACH ALLERGEN, IGG, SCFV ANTIBODY FRAGMENT, BLA G 1, IMMUNE SYSTEM
3kj4:C (GLN3) to (VAL118) STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY | NOGO RECEPTOR ANTAGONIST ANTIBODY, LRR, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, GPI-ANCHOR, LEUCINE-RICH REPEAT, LIPOPROTEIN, MEMBRANE, RECEPTOR, IMMUNE SYSTEM
5d6c:B (VAL2) to (VAL110) STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT | STAPHYLOCOCCUS AUREUS WALL TEICHOIC ACID ANTIBODY MRSA, IMMUNE SYSTEM
4p9m:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF 8ANC195 FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
1ypz:F (LYS3) to (VAL117) IMMUNE RECEPTOR | H2-T22 PROTEIN, BETA-2-MICROGLOBULIN, T CELL RECEPTOR DELTA, T-CELL RECEPTOR GAMMA CHAIN, IMMUNE SYSTEM
1n4x:H (VAL302) to (ALA420) STRUCTURE OF SCFV 1696 AT ACIDIC PH | IMMUNOGLOBULIN, IMMUNE SYSTEM
4plk:H (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plk:D (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plk:J (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plk:I (GLN1) to (SER120) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3mac:H (GLN3) to (SER119) CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062 | GP41, FAB8062, IMMUNE SYSTEM
5en2:A (VAL2) to (VAL111) MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES | IMMUNOGLOBULIN, GLYCOPROTEIN, VIRUS, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5eoc:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I | COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM
5eoc:J (VAL2) to (SER118) CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I | COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM
5esq:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5esq:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5euk:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5euk:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4qxt:A (VAL2) to (VAL112) CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN
4qyo:A (VAL2) to (VAL112) CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN
5f6i:B (VAL2) to (SER116) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH428 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5fb8:B (VAL22) to (SER140) STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY | CYTOKINE, INTERLEUKIN, ANTIBODY, COMPLEX, IMMUNE SYSTEM
5fec:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
5fec:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
3cfd:H (VAL2) to (SER112) PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN | IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM
3cfd:B (VAL2) to (SER112) PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN | IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM
3o2d:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY | IMMUNOGLOBULIN FOLD, HIV-1 PRIMARY RECEPTOR, T CELL CORECEPTOR, MONOCLONAL ANTIBODY, MEMBRANE, IMMUNE SYSTEM
4s1q:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H03+06.D- 001739, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4s1r:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H08.F-117225, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
3dgg:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF FABOX108 | ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3dgg:D (VAL2) to (SER118) CRYSTAL STRUCTURE OF FABOX108 | ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5gru:H (VAL2) to (VAL127) STRUCTURE OF MONO-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM
4d9l:H (GLN1) to (SER112) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
3duu:D (VAL2) to (VAL111) CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 2 | ANTIBODY, KDO, TWINNING, PSEUDO-SYMMETRY, IMMUNE SYSTEM
3dvn:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN | DI-UBIQUITIN, FAB FRAGMENT, ANTIBODY, NUCLEUS, PHOSPHOPROTEIN, RIBOSOMAL ROTEIN, IMMUNE SYSTEM
5hdq:H (VAL2) to (SER112) MNTC CO-STRUCTURE WITH MAB 305-78-7 | TRANSPORT PROTEIN, MONOCLONAL ANTIBODY, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3pho:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP | ANTIBODY, FAB, IGG, CARBOHYDRATE, CARBOHYDRATE-BINDING PROTEIN
5i74:B (VAL21) to (SER137) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
5id0:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5id0:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5itf:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT | IMMUNE SYSTEM
5itf:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT | IMMUNE SYSTEM
5ivz:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT | IMMUNE SYSTEM
3rhw:F (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rhw:G (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rhw:H (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rhw:I (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rhw:J (VAL2) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4g6k:H (VAL2) to (VAL118) CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, CYTOKINE, INTERLEUKINE-1BETA
4g6m:H (GLN1) to (SER119) CRYSTAL STRUCURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, INTERLEUKINE-1BETA
4g7y:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
5kzc:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM
5kzc:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM
5kzc:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM
5td8:E (VAL3) to (SER127) CRYSTAL STRUCTURE OF AN EXTENDED DWARF NDC80 COMPLEX | RWD, CH, COILED-COIL, TETRAMER, NDC80, KINETOCHORE, REPLICATION, NANOBODY
5th2:B (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5th2:D (VAL2) to (SER118) CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM